Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suning Chen

Showing results (321-330 of 368) with videos related to

Pageof 37
Sort By:
Bone Marrow Transplantation|October 17, 2022
CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemiaZhenzhen Yao, Bin Gu, Yanming Zhang, et al.
Frontiers in Cellular and Infection Microbiology|June 2, 2022
Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning RegimenYuhua Ru, Jinjin Zhu, Tiemei Song, et al.
Bone Marrow Transplantation|February 19, 2020
Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomesYuhua Ru, Xiang Zhang, Tiemei Song, et al.
Blood Science (Baltimore, Md.)|June 1, 2026
A novel <i>UBASH3B::PVT1</i> fusion in B-cell acute lymphoblastic leukemia with <i>PAX5-PTD</i>: a case report and literature reviewXinmei Zhuang, Yun Wang, Qian Yang, et al.
Haematologica|May 18, 2019
Bafilomycin A1 targets patient-derived CD34<sup>+</sup>CD19<sup>+</sup> leukemia stem cellsLi Xu, Na Yuan, Hong Liu, et al.
Frontiers in Immunology|April 4, 2022
Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T TherapyJingxian Gu, Sining Liu, Wei Cui, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2021
Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitisHong Shen, Shengsheng Zhang, Wenxia Zhao, et al.
Scientific Reports|July 2, 2025
Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myelomaYanlei Gong, Tingting Tao, Mo Zhou, et al.
Annals of Hematology|June 20, 2024
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantationXuanqi Cao, Zheng Li, Yanming Zhang, et al.
British Journal of Haematology|December 11, 2024
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathologyRong Wang, Zhongxun Shi, Yuan Zhang, et al.
Pageof 37

Showing results (321-330 of 368) with videos related to

Sort By:
Pageof 37
Bone Marrow Transplantation|October 17, 2022
CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemiaZhenzhen Yao, Bin Gu, Yanming Zhang, et al.
Frontiers in Cellular and Infection Microbiology|June 2, 2022
Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning RegimenYuhua Ru, Jinjin Zhu, Tiemei Song, et al.
Bone Marrow Transplantation|February 19, 2020
Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomesYuhua Ru, Xiang Zhang, Tiemei Song, et al.
Blood Science (Baltimore, Md.)|June 1, 2026
A novel <i>UBASH3B::PVT1</i> fusion in B-cell acute lymphoblastic leukemia with <i>PAX5-PTD</i>: a case report and literature reviewXinmei Zhuang, Yun Wang, Qian Yang, et al.
Haematologica|May 18, 2019
Bafilomycin A1 targets patient-derived CD34<sup>+</sup>CD19<sup>+</sup> leukemia stem cellsLi Xu, Na Yuan, Hong Liu, et al.
Frontiers in Immunology|April 4, 2022
Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T TherapyJingxian Gu, Sining Liu, Wei Cui, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2021
Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitisHong Shen, Shengsheng Zhang, Wenxia Zhao, et al.
Scientific Reports|July 2, 2025
Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myelomaYanlei Gong, Tingting Tao, Mo Zhou, et al.
Annals of Hematology|June 20, 2024
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantationXuanqi Cao, Zheng Li, Yanming Zhang, et al.
British Journal of Haematology|December 11, 2024
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathologyRong Wang, Zhongxun Shi, Yuan Zhang, et al.
Pageof 37